High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality.

Authors :: Danchin N
Simon T
Source :: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2020 Sep 01; Vol. 6 (5), pp. 328-330.
Publication Year :: 2020

Subjects :: Biomarkers blood
Cardiovascular Diseases mortality
Cause of Death
Clinical Trials as Topic
Down-Regulation
Dyslipidemias blood
Dyslipidemias mortality
Humans
Hypolipidemic Agents adverse effects
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Cardiovascular Diseases prevention & control
Dyslipidemias drug therapy
Hypolipidemic Agents therapeutic use
Lipids blood

Full Text Access

Tools